|
|
 |
|
| Overview |
| Anti-FITC MicroBeads are widely used for indirect magnetic labeling and separation of cells or other materials which are labeled with a primary antibody or ligand conjugated to fluorescein isothiocyanate (FITC). |
| Details |
Background information
The FITC molecule is recognized by the monoclonal anti-FITC antibody coupled to MicroBeads, allowing the positive selection or depletion of the fluorescently labeled material with MACS® Technology. Labeling samples with FITC-conjugated primary antibodies and Anti-FITC MicroBeads enables subsequent flow cytometric analysis of separated cells without any further staining of the material.
Applications
Examples among the many separations performed with Anti-FITC MicroBeads are the isolation of IgD+ B cells from human PBMCs1, the separation of plant protoplasts2 as well as the isolation of murine Langerhans cells from epidermal tissue3. Anti-FITC MicroBeads have also been used for the depletion of CD3+ cells from rat spleen and subsequent isolation of CD3- NK cells5 or the separation of murine naive CD8+ T cells expressing low levels of CD44 by depletion of CD44int/high cells6. |
| |
| Figure 1 |
| Erythrocytes from sickle cell anemia patients isolated using Annexin V-FITC and Anti-FITC MicroBeads.4 (Courtesy of Dr. Kuypers, Oakland, USA.) |
 |
|
|
|
|
| Favorites / Prices |
Request prices or add products to your favorite list.
|
| Details |
|
| Products |
| Anti-FITC MicroBeads |
- for 2×109 total cells
Download datasheet
130-048-701
|
| Anti-FITC MicroBeads – lyophilized |
| Availability: (1) |
- for 2x109 total cells
Download datasheet
130-097-050
|
| (1) Not available in Europe and the US/CAN |
|
| References |
| 1. Zan et al. (1998) J. Immunol. 161: 5217–5225. |
| 2. Barth et al. (1994) J. Biochem. Biophys. Methods 29: 83–86. |
| 3. Saeki et al. (2000) Eur. J. Immunol. 30: 2808–2814. |
| 4. Kuypers et al. (1996) Blood 87: 1179–1187. |
| 5. Mikus et al. (2001) Am. J. Respir. Cell Mol. Biol. 24: 74–82. |
| 6. Schüler et al. (2004) J. Immunol. 172: 15–19. |
|
|
|
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|
